Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001137050-15-000111
Filing Date
2015-08-13
Accepted
2015-08-13 14:20:43
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pkph10q20150630ver2clean.htm 10-Q 393550
2 EXHIBIT 31.1 exh311.htm EX-31 5646
3 EXHIBIT 31.2 exh312.htm EX-31 5635
4 EXHIBIT 32.1 exh321.htm EX-32 2096
5 EXHIBIT 32.2 exh322.htm EX-32 1984
  Complete submission text file 0001137050-15-000111.txt   1619547

Data Files

Seq Description Document Type Size
6 pkph-20150630.xml EX-101.INS 247710
7 pkph-20150630.xsd EX-101.SCH 19209
8 pkph-20150630_lab.xml EX-101.LAB 103063
9 pkph-20150630_pre.xml EX-101.PRE 96450
10 pkph-20150630_cal.xml EX-101.CAL 6340
11 pkph-20150630_def.xml EX-101.DEF 39131
Mailing Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303
Business Address 4450 ARAPAHOE AVENUE SUITE 100 BOULDER CO 80303 303-415-2557
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 151050104
SIC: 2834 Pharmaceutical Preparations